Fatal pulmonary embolism during liver transplantation

Anesthesiology

Volumn 87, Issue 2, 1997, Pages 429-432

  Sopher, Michael ^b   Braunfeld, Michelle ^b   Shackleton, Christopher ^b   Busuttil, Ronald W ^b   Sangwan, Susheela ^b   Csete, Marie ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b NONE

Author keywords

Aprotinin; Epsilon amino caproic acid; Liver transplantation; Pulmonary embolus

Indexed keywords

ANTIFIBRINOLYTIC AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; LUNG EMBOLISM; MALE; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION; RISK ASSESSMENT; SURGICAL ANATOMY; SURGICAL RISK; THROMBECTOMY;

6-AMINOCAPROIC ACID; ADULT; ANTIFIBRINOLYTIC AGENTS; APROTININ; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PULMONARY EMBOLISM; SERINE PROTEINASE INHIBITORS;

EID: 0030806043     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199708000-00033     Document Type: Article

References (23)

1. Violi F, Ferro D, Basili S, Saliola M, Quintarelli C, Alessandri C, Cordova C: Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology 1995; 109:531-9
2. Porte RJ, Bontempo FA, Knot EAR, Lewis JH, Kang YG, Starzl TE: Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation 1989; 47:978-84
3. Kang Y, Lewis HJ, Navalgund A, Russell MW, Bontempo FA, Niren LS, Starzl TE: Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. ANESTHESIOLOGY 1987; 66:766-73
4. Pohorecki R, Landers DF, Peters RK, et al: Effect of e-aminocaproic acid on blood product usage during orthotopic liver transplantation: A double blind, prospective study. Presented at American Society of Transplant Surgeons, May 1992, Houston, Texas.
5. Grosse H, Lobbes W, Framback M, von Broen O, Ringe B, Barthels M: The use of high dose aprotinin in liver transplantation: The influence of fibrinolysis and blood loss. Thrombosis Res 1991; 63:287-97
6. Patrassi GM, Viero M, Sartori MT, De Silvestro G, Rossaro L, Burra P, Nolli ML, Piccinni P, Bassi N: Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation. Transfusion 1994; 34:507-11
7. Smith O, Hazlehurst G, Brozovic B, Rolles K, Burroughs A, Mallett S, Dawson K, Mehta A: Impact of aprotinin on blood transfusion requirements in liver transplantation. Transfusion Med 1993; 3:97-102
8. Gerlach H, Rossaint R, Slama K, Streich R, Keitel M, Blumhardt G, Bechstein W, Lemmens P, Lohmann R, Heuhaus P: No requirement for cryoprecipitate or platelet transfusion during liver transplantation. Transplant Proc 1993; 25:1813-6
9. Scudamore CH, Randall RE, Jewesson PJ, Shackleton CR, Salvian AJ, Fagan M, Frighetto L, Growe GH, Scarth I, Erb SR: Aprotinin reduces the need for blood products during liver transplantation. Am J Surg 1995; 169:546-9
10. Himmelreich G, Muser M, Neuhaus P, Bechstein WO, Slama KJ, Jochum M, Riess H: Different aprotinin applications influencing hemostatic changes in orthotopic liver transplantation. Transplantation 1992; 53:132-6
11. Soilleux H, Gillon MC, Mirand A, Daibes M, Leballe F, Ecoffey C: Comparative effects of small and large aprotinin doses on bleeding during orthotopic liver transplantation. Anesth Analg 1995; 80:349-52
12. Segal HC, Hunt BJ, Cottam S, Beard C, Francis JL, Potter D, Tan KC: Changes in the contact system during orthotopic liver transplantation with and without aprotinin. Transplantation 1995; 59:366-70
13. Himmelreich G, Jochum M, Bechstein WO, Machleidt W, Neuhaus PI, Slama KJ, Riess H: Mediators of leukocyte activation play a role in disseminated intravascular coagulation during orthotopic liver transplantation. Transplantation 1994; 57:354-8
14. Garcia L, Sabate A, Domenech P, Martinez Brotons F, Drudis R, Jaurrieta E: Aprotinin in orthotopic liver transplantation. Transplant Proc 1995; 27:2290-1
15. Baubillier E, Cherqui D, Dominique C, Khalil M, Bonnet F, Fagniez PL, Duvaldestin P: A fatal thrombotic complication during liver transplantation after aprotinin administration. Transplantation 1994; 57:1664-6
16. Sandey EA, Crow J, Mallett SV, Alcock RJ, More L, Burroughs AK, Rolles K: Pulmonary platelet aggregates: Possible cause of sudden peroperative death in adults undergoing liver transplantation. J Clin Pathol 1993; 46:222-7
17. Navalgund AA, Kang Y, Sarner JB, Jahr JS, Gieraerts R: Massive pulmonary thromboembolism during liver transplantation. Anesth Analg 1988; 67:400-2
18. Farrell FJ, Nguyen M, Woodley S, Imperial JC, Garcia-Kennedy R, Man K, Esquivel CO, Keeffe EB: Outcome of liver transplantation in patients with hemochromatosis. Hepatology 1994; 20:404-10
19. Ellis JE, Lichtor JL, Feinstein SB, Chung MR, Polk SL, Broelsch C, Emond J, Thistlethwaite JR, Roizen MF: Right heart dysfunction, pulmonary embolism, and paradoxical embolization during liver transplantation. A transesophageal two-dimensional study. Anesth Analg 1989; 68:777-82
20. Prah GN, Lisman SR, Maslow AD, Freeman RB, Rohrer RJ: Transesophageal echocardiography reveals an unusual cause of hemodynamic collapse during orthotopic liver transplantation - Two case reports. Transplantation 1995; 59:921-5
21. Langley PG, Hughes RD, Forbes A, Keays R, Williams R: Controlled trial of antithrombin III supplementation in fulminant hepatic failure. J Hepatology 1993; 17:326-31
22. Marcel RJ, Stegall WC, Suit CT, Arnold JC, Vera RL, Ramsay MA, O'Donnell MB, Swygert TH, Hein HA, Whitten CW: Continuous small-dose aprotinin controls fibrinolysis during orthotopic liver transplantation. Anesth Analg 1996; 82:1122-5
23. Velasco R, Villalba R, Fernandez M, de la Mata M, Roman J, Rubio V, Rufian S, Varo E, Pera C, Torres A: Diminished anticoagulant and fibrinolytic activity following liver transplantation. Transplantation 1992; 53:1256-61